Showing results (11-20 of 257) with videos related to
Sort By:
Pageof 26
Critical Reviews in Oncology/Hematology|April 22, 2017
Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trialsGiandomenico Roviello, Chiara Pacifico, Giorgio Chiriacò, et al.Frontiers in Cell and Developmental Biology|April 8, 2021
Role of the IGF-1 Axis in Overcoming Resistance in Breast CancerAnna Ianza, Marianna Sirico, Ottavia Bernocchi, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 14, 2018
Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experienceGiandomenico Roviello, Daniele Generali, Michele Aieta, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 20, 2026
Budget impact analysis of Oncotype DX® multigenic prognostic test in patients with early breast cancer in ItalyOriana Ciani, Carlo Federici, Daniele Generali, et al.Breast Cancer Research and Treatment|October 15, 2010
"Overcoming breast cancer drug resistance with mTOR inhibitors". Could it be a myth or a real possibility in the short-term future?Nadia Margariti, Stephen B Fox, Alberto Bottini, et al.Genes & Cancer|July 7, 2017
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesotheliomaNavid Sobhani, Silvia P Corona, Fabrizio Zanconati, et al.Cells|February 4, 2021
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast CancerNavid Sobhani, Anne Fassl, Giuseppina Mondani, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancerDaniele Generali, William F Symmans, Alfredo Berruti, et al.Journal of the National Cancer Institute. Monographs|November 2, 2011
New omics information for clinical trial utility in the primary settingGiovanna Damia, Massimo Broggini, Silvia Marsoni, et al.Genes|April 26, 2025
Current Trends in Liquid Biopsy Tracking Resistance in Molecular Breast Cancer-Targeted TherapiesRichard Tancredi, Navid Sobhani, Martina Catalano, et al.Pageof 26